ELI LILLY & Co
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Eli Lilly and Company
| By | /s/ David Ricks |
|---|---|
| David Ricks | |
| Chair, President, and Chief Executive Officer | |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below on February 19, 2025 by the following persons on behalf of the Registrant and in the capacities indicated.
| Signature | Title |
|---|---|
| /s/ David Ricks | Chair, President, and Chief Executive Officer (principal executive officer) |
| DAVID RICKS | |
| /s/ Lucas Montarce | Executive Vice President and Chief Financial Officer (principal financial officer) |
| LUCAS MONTARCE | |
| /s/ Donald Zakrowski | Senior Vice President, Finance, and Chief Accounting Officer (principal accounting officer) |
| DONALD ZAKROWSKI | |
| /s/ Ralph Alvarez | Director |
| RALPH ALVAREZ | |
| /s/ Katherine Baicker, Ph.D. | Director |
| KATHERINE BAICKER, Ph.D. | |
| /s/ Erik Fyrwald | Director |
| ERIK FYRWALD | |
| /s/ Mary Lynne Hedley, Ph.D. | Director |
| MARY LYNNE HEDLEY, Ph. D. | |
| /s/ Jamere Jackson | Director |
| JAMERE JACKSON | |
| /s/ Kimberly Johnson | Director |
| KIMBERLY JOHNSON | |
| /s/ William Kaelin, Jr., M.D. | Director |
| WILLIAM KAELIN, JR., M.D. | |
| /s/ Juan Luciano | Director |
| JUAN LUCIANO | |
| /s/ Jon Moeller | Director |
| JON MOELLER | |
| /s/ Gabrielle Sulzberger | Director |
| GABRIELLE SULZBERGER | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.